Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From RenovoRx, Inc.
Renaissance Capital expects an initial public offering surge in September; Biomedtracker data show financings for COVID-19 programs fell from Q1 to Q2; Revelation will merge with a special purpose acquisition corporation; Ascendis netted $379.3m in a follow-on offering; and Disc Medicine raised $90m in venture capital.
New VC deals include a $60m series C-1 round for DiCE Molecules a day before it filed paperwork to support a $100m IPO and a $100m financing for China’s IONOVA Life Science. Also, RenovoRx was the 84th company to go public in the US this year and ADC Therapeutics executed a $325m royalty deal.
Start-Up Spotlight 2018: Biosensors, Hemodynamic Monitor, Catheter-Based Technologies, And Big Data Shine Brightest
The most widely-read 2018 Start-Up Spotlight profiles pointed to a diversity of reader interest -- biosensors, catheters, and AI and big data.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- Site Specific
- Drug Delivery
- Infusion Therapy Equipment and Supplies